NO964667L - Purin-6-on-derivater - Google Patents
Purin-6-on-derivaterInfo
- Publication number
- NO964667L NO964667L NO964667A NO964667A NO964667L NO 964667 L NO964667 L NO 964667L NO 964667 A NO964667 A NO 964667A NO 964667 A NO964667 A NO 964667A NO 964667 L NO964667 L NO 964667L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- formula
- purin
- stands
- residue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541264A DE19541264A1 (de) | 1995-11-06 | 1995-11-06 | Purin-6-on-derivate |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964667D0 NO964667D0 (no) | 1996-11-05 |
NO964667L true NO964667L (no) | 1997-05-07 |
Family
ID=7776713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964667A NO964667L (no) | 1995-11-06 | 1996-11-05 | Purin-6-on-derivater |
Country Status (23)
Country | Link |
---|---|
US (1) | US5861396A (zh) |
EP (1) | EP0771799A1 (zh) |
JP (1) | JPH09124648A (zh) |
KR (1) | KR970027082A (zh) |
AR (1) | AR004545A1 (zh) |
AU (1) | AU720305B2 (zh) |
BR (1) | BR9605434A (zh) |
CA (1) | CA2189401A1 (zh) |
CO (1) | CO4770977A1 (zh) |
CZ (1) | CZ325096A3 (zh) |
DE (1) | DE19541264A1 (zh) |
EE (1) | EE9600172A (zh) |
HU (1) | HU217691B (zh) |
IL (1) | IL119559A0 (zh) |
MX (1) | MX9605371A (zh) |
NO (1) | NO964667L (zh) |
NZ (1) | NZ299683A (zh) |
PL (1) | PL316816A1 (zh) |
SG (1) | SG64953A1 (zh) |
SK (1) | SK142596A3 (zh) |
TR (1) | TR199600883A2 (zh) |
TW (1) | TW360656B (zh) |
ZA (1) | ZA969278B (zh) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69815554T2 (de) * | 1998-01-05 | 2004-05-06 | Eisai Co., Ltd. | Purinderivate und antagonisten des adenosin-a2-rezeptors, welche zur vorsorge oder heilung von diabetes dienen |
DE19838705A1 (de) | 1998-08-26 | 2000-03-02 | Bayer Ag | Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one |
GB9828340D0 (en) * | 1998-12-22 | 1999-02-17 | Novartis Ag | Organic compounds |
US20050020547A1 (en) * | 1999-11-08 | 2005-01-27 | Pfizer Inc. | Compounds for the treatment of female sexual dysfunction |
IL139457A0 (en) * | 1999-11-08 | 2001-11-25 | Pfizer | Compounds for the treatment of female sexual dysfunction |
ES2233685T3 (es) * | 2000-08-01 | 2005-06-16 | Bayer Healthcare Ag | Inhibidores selectivos de pde 2 como medicamentos para mejorar la percepcion. |
US20020065286A1 (en) * | 2000-08-21 | 2002-05-30 | Davies Michael John | Treatment of wounds |
AU2001284444B2 (en) * | 2000-09-06 | 2006-05-25 | Mitsubishi Tanabe Pharma Corporation | Preparations for oral administration |
DE10064105A1 (de) | 2000-12-21 | 2002-06-27 | Bayer Ag | Neue Substituierte Imidazotriazinone |
DE60236850D1 (de) * | 2001-02-15 | 2010-08-12 | Mitsubishi Tanabe Pharma Corp | Tabletten, die in der mundhöhle schnell zerfallen |
CZ20032258A3 (cs) | 2001-02-23 | 2004-01-14 | Merck & Co., Inc. | N-substituované nearylové heterocyklické sloučeniny |
US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
PL370599A1 (en) * | 2001-11-02 | 2005-05-30 | Pfizer Products Inc. | Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
CA2517336A1 (en) * | 2003-03-04 | 2004-10-21 | Altana Pharma Ag | Purin-6-one-derivatives |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
GB0314054D0 (en) * | 2003-06-17 | 2003-07-23 | Pfizer Ltd | Amide derivatives as selective serotonin re-uptake inhibitors |
US20050054688A1 (en) * | 2003-08-08 | 2005-03-10 | Pfizer Inc | Selective serotonin reuptake inhibitors in the treatment of disease |
AU2004268387A1 (en) * | 2003-08-28 | 2005-03-10 | Nycomed Gmbh | Composition comprising a pulmonary surfactant and a PDE2 inhibitor |
US7291640B2 (en) * | 2003-09-22 | 2007-11-06 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
WO2006100588A1 (en) * | 2005-03-21 | 2006-09-28 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
ES2313626T3 (es) * | 2005-03-21 | 2009-03-01 | Pfizer Limited | Derivados de triazol sustituidos como antagonistas de oxitocina. |
US20100222365A1 (en) * | 2005-08-10 | 2010-09-02 | Pfizer Inc | Substituted triazole deriviatives as oxytocin antagonists |
JP6696904B2 (ja) | 2014-01-08 | 2020-05-20 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 製剤および医薬組成物 |
RU2702732C1 (ru) | 2014-12-06 | 2019-10-10 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
BR112017012007B1 (pt) | 2014-12-06 | 2022-11-01 | Intra-Cellular Therapies, Inc | Compostos orgânicos inibitórios de pde2, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento de um distúrbio mediado por pde2 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
IL76546A (en) * | 1984-10-12 | 1988-12-30 | Warner Lambert Co | 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them |
EP0290630A4 (de) * | 1986-11-25 | 1990-02-26 | Inst Organicheskogo Sinteza Ak | 9-substituierte guanine. |
IT1241452B (it) * | 1990-06-28 | 1994-01-17 | Sigma Tau Ind Farmaceuti | Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono |
-
1995
- 1995-11-06 DE DE19541264A patent/DE19541264A1/de not_active Withdrawn
-
1996
- 1996-10-24 EP EP96117155A patent/EP0771799A1/de not_active Withdrawn
- 1996-10-30 US US08/739,742 patent/US5861396A/en not_active Expired - Fee Related
- 1996-10-31 AU AU70532/96A patent/AU720305B2/en not_active Ceased
- 1996-11-01 NZ NZ299683A patent/NZ299683A/en unknown
- 1996-11-01 CA CA002189401A patent/CA2189401A1/en not_active Abandoned
- 1996-11-04 PL PL96316816A patent/PL316816A1/xx unknown
- 1996-11-04 TW TW085113407A patent/TW360656B/zh active
- 1996-11-04 IL IL11955996A patent/IL119559A0/xx unknown
- 1996-11-05 CZ CZ963250A patent/CZ325096A3/cs unknown
- 1996-11-05 NO NO964667A patent/NO964667L/no unknown
- 1996-11-05 MX MX9605371A patent/MX9605371A/es unknown
- 1996-11-05 SK SK1425-96A patent/SK142596A3/sk unknown
- 1996-11-05 EE EE9600172A patent/EE9600172A/xx unknown
- 1996-11-05 KR KR1019960051978A patent/KR970027082A/ko not_active Application Discontinuation
- 1996-11-05 SG SG1996011041A patent/SG64953A1/en unknown
- 1996-11-05 ZA ZA969278A patent/ZA969278B/xx unknown
- 1996-11-06 JP JP8308604A patent/JPH09124648A/ja active Pending
- 1996-11-06 TR TR96/00883A patent/TR199600883A2/xx unknown
- 1996-11-06 AR ARP960105076A patent/AR004545A1/es unknown
- 1996-11-06 HU HU9603071A patent/HU217691B/hu not_active IP Right Cessation
- 1996-11-06 CO CO96058501A patent/CO4770977A1/es unknown
- 1996-11-06 BR BR9605434A patent/BR9605434A/pt unknown
Also Published As
Publication number | Publication date |
---|---|
HU217691B (hu) | 2000-03-28 |
ZA969278B (en) | 1997-06-02 |
CZ325096A3 (en) | 1997-06-11 |
AR004545A1 (es) | 1998-12-16 |
CO4770977A1 (es) | 1999-04-30 |
JPH09124648A (ja) | 1997-05-13 |
HUP9603071A3 (en) | 1998-04-28 |
US5861396A (en) | 1999-01-19 |
CA2189401A1 (en) | 1997-05-07 |
TR199600883A2 (tr) | 1997-05-21 |
DE19541264A1 (de) | 1997-05-07 |
EP0771799A1 (de) | 1997-05-07 |
SK142596A3 (en) | 1997-05-07 |
TW360656B (en) | 1999-06-11 |
BR9605434A (pt) | 1998-08-04 |
NZ299683A (en) | 1998-09-24 |
AU720305B2 (en) | 2000-05-25 |
NO964667D0 (no) | 1996-11-05 |
AU7053296A (en) | 1997-05-15 |
HUP9603071A2 (en) | 1997-05-28 |
EE9600172A (et) | 1997-06-16 |
KR970027082A (ko) | 1997-06-24 |
SG64953A1 (en) | 1999-05-25 |
MX9605371A (es) | 1997-05-31 |
IL119559A0 (en) | 1997-02-18 |
HU9603071D0 (en) | 1996-12-30 |
PL316816A1 (en) | 1997-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964667L (no) | Purin-6-on-derivater | |
HUT36840A (en) | Process for producing 11-beta-estradiene derivatives and pharmaceutical compositions containing them | |
MX9203762A (es) | Administracion de monoaminacridinas en estados deficientes en colinergicos-neuronales. | |
MY102866A (en) | Amide derivatives. | |
IL143978A0 (en) | Colchinol derivatives as vascular damaging agents | |
NO954453L (no) | Nye pyridin-, pyrimidin- og benzenderivater som adreno-ceptorantagonister | |
MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
ATE250623T1 (de) | 4'-c-ethynyl-purin-nukleoside | |
UA41869C2 (uk) | Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування | |
DE3873870T2 (de) | Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. | |
ATE90676T1 (de) | Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung. | |
DE68923151D1 (de) | Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen. | |
ATE171374T1 (de) | Verwendung von 1-(aminoalkyl)-3-quinoxalin-2-on derivaten zur herstellung von neuroprotektiven mitteln | |
FI884968A (fi) | Menetelmä lääkeaineena käyttökelpoisten oktahydronaftaleenioksiimin johdannaisten valmistamiseksi | |
DE69719511T2 (de) | Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung | |
ES2152563T3 (es) | Procedimiento para preparar derivados de dihidroxipirimidina. | |
MX9708735A (es) | Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos. | |
DE3480839D1 (de) | Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung. | |
ATE5961T1 (de) | N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
TR200003877T2 (tr) | İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri | |
NO963374L (no) | Substituerte 4H-pyraner | |
ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
AU658175B2 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
HU9301415D0 (en) | Octahydro-naphtaline-oxime derivatives inhibiting biological synthesis of cholesterol | |
NO974747L (no) | Fremgangsmåte for fremstilling av streptograminer |